Trodusquemine
Trodusquemine
Trodusquemine (pronunciation: tro-duh-skwuh-meen) is a drug that is currently under research and development for potential therapeutic uses. It is a selective inhibitor of the enzyme Protein Tyrosine Phosphatase 1B (PTP1B) and alkaline phosphatase (ALP), which are involved in the regulation of insulin and leptin signaling respectively.
Etymology
The term "Trodusquemine" does not have a known etymology as it is a coined term for this specific drug. It is common in the pharmaceutical industry to create unique names for new drugs.
Related Terms
- Enzyme: A protein that acts as a biological catalyst to speed up chemical reactions in cells.
- PTP1B: Protein Tyrosine Phosphatase 1B, an enzyme that negatively regulates insulin signaling.
- Alkaline phosphatase: An enzyme found in several tissues throughout the body, most commonly in the liver, bone, kidney, and gastrointestinal tract.
- Insulin: A hormone produced in the pancreas that regulates the amount of glucose in the blood.
- Leptin: A hormone that helps to regulate energy balance by inhibiting hunger.
See Also
External links
- Medical encyclopedia article on Trodusquemine
- Wikipedia's article - Trodusquemine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski